20.09.2017 15:40:06

DGAP-Gesamtstimmrechte: B.R.A.I.N. Biotechnology Research and Information Network AG

DGAP-NVR: B.R.A.I.N. Biotechnology Research And Information Network AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

DGAP Total Voting Rights Announcement: B.R.A.I.N. Biotechnology Research And Information Network AG / Total Voting Rights Announcement
B.R.A.I.N. Biotechnology Research And Information Network AG: Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

20.09.2017 / 15:40
Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of total number of voting rights

1. Details of issuer
B.R.A.I.N. Biotechnology Research And Information Network AG
Darmstädter Straße 34-36
64673 Zwingenberg
Germany

2. Type of capital measure
  Type of capital measure Date of status / date of effect
  Conditional capital increase (Sec. 26a para. 2 WpHG)
X Other capital measure (Sec. 26a para. 1 WpHG) 15 Sep 2017

3. New total number of voting rights:
18055782



20.09.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: B.R.A.I.N. Biotechnology Research And Information Network AG
Darmstädter Straße 34-36
64673 Zwingenberg
Germany
Internet: www.brain-biotech.de

 
End of News DGAP News Service

611405  20.09.2017 

fncls.ssp?fn=show_t_gif&application_id=611405&application_name=news&site_id=smarthouse

Analysen zu BRAIN Biotech AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

BRAIN Biotech AG 3,46 -3,35% BRAIN Biotech AG